Abstract

Data on dementia prevalence in Europe are primarily based on studies from Western Europe. Central and Eastern European countries differ from Western European countries in their average income and other socioeconomic and health factors that are relevant for dementia risk. We, therefore, conducted a systematic review of population-based studies on prevalence of dementia in Central and Eastern Europe. We searched in electronic databases from the date of inception up to July 2019, updated in October 2020. We hand-searched references of included articles and contacted experts in each country to identify further articles. We combined studies by meta-analysis where possible. Ten population-based studies (n = 30,268) met inclusion criteria. We meta-analysed seven studies (n = 11,994). The selected studies were conducted across 5 countries with no studies identified for the vast majority of countries in this region. Prevalence of all-cause dementia was 6.7% (95% CI 5.1–8.2) in those aged 60 or over, and 7.1% (95% CI 5.1–9.2) in those aged 65 and over. Prevalence rates were similar to those in Western Europe, but are increasing over time, compared with the patterns of reduction in age-specific prevalence in Western Europe.

Highlights

  • The estimated number of people living with dementia worldwide was 46.8 million in 2015, while this number is expected to reach 74.7 million in 2030 and 131.5 million in2050 [1]

  • A 2012 report on Dementia published by the World Health Organisation estimated that approximately 14 million people will suffer from some form of dementia in Europe by

  • We found a higher the first review of dementia prevalence in this region since 2006

Read more

Summary

Introduction

The estimated number of people living with dementia worldwide was 46.8 million in 2015, while this number is expected to reach 74.7 million in 2030 and 131.5 million in2050 [1]. The estimated number of people living with dementia worldwide was 46.8 million in 2015, while this number is expected to reach 74.7 million in 2030 and 131.5 million in. A 2012 report on Dementia published by the World Health Organisation estimated that approximately 14 million people will suffer from some form of dementia in Europe by. It is anticipated that by 2030, dementia cost in Europe will exceed €250 bn, a rise of 43% between 2008 and 2030 [4]. Population based studies of prevalence are fundamental to understanding the societal burden of dementia. They provide essential information for the planning of healthcare services that are required to meet the needs of the people with the condition and their carers

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call